INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 451m ago
House PTR51m ago
SEC 13F51m ago
Robinhood Chain51m ago

Results

8,832 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$28.69M
1.89M sh
Sep 9, 2026Sep 9, 2026
Page 41 of 221
← PrevNext →
traded Sep 9, 2026
+0d
SEC Form 4

Evidence

36
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.39M
8,843 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

36
April McClain DelaneyDDependent child
ITTITT INC.
Sale
SELL$250K – $500KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

36
CM
Carlson MeganCAO and SVP, Finance
BFLYButterfly Network, Inc.
Open-market sale
SELL$101K
13.8K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

36
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.39M
8,843 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

35
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$88K
2,890 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

35
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$989K
23.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

35
April McClain DelaneyDDependent child
MFPMidera Food Processing, Inc.
Sale
SELL$15K – $50KAug 3, 2026Sep 9, 2026
traded Aug 3, 2026
+37dHouse PTR

Evidence

35
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$485K
5,386 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

34
SF
Sluis FrankCFO
ONONOn Holding AG
Open-market sale
SELL$19K
687 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

34
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Open-market sale · 10b5-1 plan
SELL$6.98M
464.2K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

34
Brandon GillRSelf
RERSP ETF
Purchase
BUY$50K – $100KAug 13, 2026Sep 9, 2026
traded Aug 13, 2026
+27dHouse PTR

Evidence

33
April McClain DelaneyDDependent child
ENTGENTEGRIS INC
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

32
Maria Elvira SalazarRSelf
IBMINTERNATIONAL BUSINESS MACHINES CORP
Partial sale
SELL$1,001 – $15KAug 24, 2026Sep 9, 2026
traded Aug 24, 2026
+16dHouse PTR

Evidence

32
Maria Elvira SalazarRSelf
IBMINTERNATIONAL BUSINESS MACHINES CORP
Partial sale
SELL$1,001 – $15KAug 24, 2026Sep 9, 2026
traded Aug 24, 2026
+16dHouse PTR

Evidence

32
CA
Clerc AlexandreSVP, Customers
ULCCFrontier Group Holdings, Inc.
Open-market sale
SELL$20K
3,480 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,590 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

32
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$24K
800 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

32
CS
Chin Peter ScottChief Medical Officer
DNLIDenali Therapeutics Inc.
Open-market sale
SELL$37K
1,654 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$40K
20.1K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

31
April McClain DelaneyDDependent child
CPAYCORPAY, INC.
Partial sale
SELL$15K – $50KAug 6, 2026Sep 9, 2026
traded Aug 6, 2026
+34dHouse PTR

Evidence

31
April McClain DelaneyDDependent child
CPAYCORPAY, INC.
Sale
SELL$15K – $50KAug 7, 2026Sep 9, 2026
traded Aug 7, 2026
+33dHouse PTR

Evidence

31
Maria Elvira SalazarRSelf
CBChubb Ltd
Sale
SELL$15K – $50KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

31
April McClain DelaneyDDependent child
ESEESCO TECHNOLOGIES INC
Sale
SELL$15K – $50KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

31
April McClain DelaneyDDependent child
LHLABCORP HOLDINGS INC.
Partial sale
SELL$1,001 – $15KAug 5, 2026Sep 9, 2026
traded Aug 5, 2026
+35dHouse PTR

Evidence

31
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$458K
5,387 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$518K
11.7K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
April McClain DelaneyDDependent child
TRMBTRIMBLE INC.
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

30
April McClain DelaneyDDependent child
SIGSIGNET JEWELERS LTD
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$793K
17.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

56
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$1.03M
55.0K sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence

56
SA
Stamler David AllenDirector, Chief Executive Officer
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

56
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

52
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

51
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$114K
35.0K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

51
RW
Roeder Clinton WilliamChief Financial Officer
TISITEAM INC
Open-market purchase
BUY$221K
8,000 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

48
MJ
Meyer-Gloeckner Birger JohannesDirector
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$44K
1,531 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

46
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$1.60M
900.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

46
WJ
Wambeke David J.Chief Business Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Open-market purchase
BUY$67K
33.3K sh
Aug 27, 2026Sep 8, 2026
traded Aug 27, 2026
+12dSEC Form 4

Evidence

43
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$101K
33.0K sh
Sep 2, 2026Sep 8, 2026
traded Sep 2, 2026
+6dSEC Form 4

Evidence